The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so I think I already alluded to one of them canaga flows in and I think it's probably the one for which we have the most data it was approved exactly 10 years ago uh so in 2013 um and was looked at both in isolation and in combination with metformin which was obviously the standard of care for initiation therapy it it in many ways still is
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.